Price Don’t Lie: Will Ventas, Inc. Short Squeeze Soon?

Price Don't Lie: Will Ventas, Inc. Short Squeeze Soon?

The stock of Ventas, Inc. (NYSE:VTR) is a huge mover today! The stock decreased 1.77% or $1.27 during the last trading session, hitting $70.63. Ventas, Inc. (NYSE:VTR) has risen 26.87% since February 29, 2016 and is uptrending. It has outperformed by 16.45% the S&P500.
The move comes after 6 months negative chart setup for the $25.09B company. It was reported on Oct, 1 by Barchart.com. We have $67.10 PT which if reached, will make NYSE:VTR worth $1.25 billion less.

Analysts await Ventas, Inc. (NYSE:VTR) to report earnings on October, 28. They expect $1.01 earnings per share, down 7.34% or $0.08 from last year’s $1.09 per share. VTR’s profit will be $358.78M for 17.48 P/E if the $1.01 EPS becomes a reality. After $1.04 actual earnings per share reported by Ventas, Inc. for the previous quarter, Wall Street now forecasts -2.88% negative EPS growth.

Ventas, Inc. (NYSE:VTR) Ratings Coverage

Out of 10 analysts covering Ventas Inc. (NYSE:VTR), 0 rate it a “Buy”, 0 “Sell”, while 10 “Hold”. This means 0 are positive. Ventas Inc. has been the topic of 26 analyst reports since July 27, 2015 according to StockzIntelligence Inc. The stock of Ventas, Inc. (NYSE:VTR) earned “Neutral” rating by Mizuho on Wednesday, November 11. The firm has “Neutral” rating by Goldman Sachs given on Thursday, March 24. The stock has “Hold” rating given by Argus Research on Wednesday, July 13. UBS maintained Ventas, Inc. (NYSE:VTR) rating on Friday, May 20. UBS has “Neutral” rating and $53 price target. The rating was maintained by UBS with “Neutral” on Tuesday, August 23. BTIG Research initiated Ventas, Inc. (NYSE:VTR) on Thursday, August 25 with “Neutral” rating. Mizuho downgraded it to “Neutral” rating and $58 target price in Monday, October 26 report. The firm earned “Market Perform” rating on Tuesday, July 26 by Raymond James. Stifel Nicolaus downgraded the shares of VTR in a report on Tuesday, February 16 to “Hold” rating. The firm has “Outperform” rating by BMO Capital Markets given on Monday, July 27.

According to Zacks Investment Research, “Ventas, Inc. is a healthcare real estate investment trust.”

Insitutional Activity: The institutional sentiment decreased to 1.26 in 2016 Q2. Its down 0.34, from 1.6 in 2016Q1. The ratio turned negative, as 40 funds sold all Ventas, Inc. shares owned while 189 reduced positions. 58 funds bought stakes while 231 increased positions. They now own 309.67 million shares or 1.99% less from 315.96 million shares in 2016Q1.
Hl Financial Llc, a Kentucky-based fund reported 12,342 shares. Spot Trading Limited Liability accumulated 0% or 2,349 shares. Brown Brothers Harriman And, a New York-based fund reported 40 shares. Gerstein Fisher has 7,651 shares for 0.07% of their US portfolio. Phocas Corporation accumulated 12,511 shares or 0.07% of the stock. Qs Invsts Limited Liability Company holds 0.01% of its portfolio in Ventas, Inc. (NYSE:VTR) for 9,237 shares. The Tennessee-based Laffer has invested 0% in Ventas, Inc. (NYSE:VTR). Shoker Investment Counsel has 0.43% invested in the company for 6,674 shares. Presima holds 0.35% of its portfolio in Ventas, Inc. (NYSE:VTR) for 30,400 shares. Gradient Lc reported 460 shares or 0% of all its holdings. Northern Tru last reported 6.37 million shares in the company. Investec Asset Management Ltd last reported 214,883 shares in the company. The California-based Schnieders Mngmt Ltd Liability has invested 0.89% in Ventas, Inc. (NYSE:VTR). Moreover, Plante Moran Limited Liability Corp has 0.07% invested in Ventas, Inc. (NYSE:VTR) for 1,362 shares. Kistler has 1,684 shares for 0.06% of their US portfolio.

Insider Transactions: Since August 2, 2016, the stock had 0 insider purchases, and 4 sales for $18.19 million net activity. Another trade for 60,000 shares valued at $4.50 million was sold by Cobb John D.. On Tuesday, August 16 the insider RINEY T RICHARD sold $12.37 million. Liebbe Gregory R also sold $508,225 worth of Ventas, Inc. (NYSE:VTR) shares. CAFARO DEBRA A sold $807,562 worth of Ventas, Inc. (NYSE:VTR) on Friday, August 12.

Another recent and important Ventas, Inc. (NYSE:VTR) news was published by Forbes.com which published an article titled: “Ex-Dividend Reminder: Comerica, Ventas and RenaissanceRe Holdings” on September 09, 2016.

VTR Company Profile

Ventas, Inc., incorporated on June 22, 1987, is a healthcare real estate investment trust (REIT) with its properties located throughout the United States, Canada and the United Kingdom. The Firm operates through three divisions: triple-net leased properties, senior living activities and medical office building (MOB) operations. In its triple-net leased properties segment, the Company acquires and owns seniors housing and healthcare properties throughout the United States and the United Kingdom. Through its senior living activities segment, the Company invests in seniors housing communities throughout the United States and Canada, and engages independent operators to manage approximately 304 of its seniors housing communities. In its MOB activities segment, the Company primarily acquires, owns, develops, leases and manages MOBs. The Firm primarily invests in seniors housing and healthcare properties through acquisitions and leases its properties to unaffiliated tenants or operates them through independent third-party managers. It leases approximately 575 properties to various healthcare operating companies under triple-net or absolute-net leases that obligate the tenants to pay all property-related expenses, including maintenance, utilities, repairs, taxes, insurance and capital expenditures.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Tags: , ,

Leave a Comment